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Abstract
Background: Transfer RNAs are synthesized as a primary transcript that is processed to produce a mature tRNA. As part of
the maturation process, a subset of the nucleosides are modified. Modifications in the anticodon region often modulate the
decoding ability of the tRNA. At position 34, the majority of yeast cytosolic tRNA species that have a uridine are modified to
5-carbamoylmethyluridine (ncm5U), 5-carbamoylmethyl-29-O-methyluridine (ncm5Um), 5-methoxycarbonylmethyl-uridine
(mcm5U) or 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U). The formation of mcm5 and ncm5 side chains involves a
complex pathway, where the last step in formation of mcm5 is a methyl esterification of cm5 dependent on the Trm9 and
Trm112 proteins.
Methodology and Principal Findings: Both Trm9 and Trm112 are required for the last step in formation of mcm5 side
chains at wobble uridines. By co-expressing a histidine-tagged Trm9p together with a native Trm112p in E. coli, these two
proteins purified as a complex. The presence of Trm112p dramatically improves the methyltransferase activity of Trm9p in
vitro. Single tRNA species that normally contain mcm5U or mcm5s2U nucleosides were isolated from trm9D or trm112D
mutants and the presence of modified nucleosides was analyzed by HPLC. In both mutants, mcm5U and mcm5s2U
nucleosides are absent in tRNAs and the major intermediates accumulating were ncm5U and ncm5s2U, not the expected
cm5U and cm5s2U.
Conclusions: Trm9p and Trm112p function together at the final step in formation of mcm5U in tRNA by using the
intermediate cm5U as a substrate. In tRNA isolated from trm9D and trm112D strains, ncm5U and ncm5s2U nucleosides
accumulate, questioning the order of nucleoside intermediate formation of the mcm5 side chain. We propose two
alternative explanations for this observation. One is that the intermediate cm5U is generated from ncm5U by a yet unknown
mechanism and the other is that cm5U is formed before ncm5U and mcm5U.
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Introduction
Transfer RNAs are adapter molecules, which decode mRNA
into protein and thereby play a central role in gene expression.
The primary tRNA transcript is processed by different endo and
exonucleases, and tRNA modifying enzymes to produce a mature
tRNA [1,2,3]. In this maturation process, a subset of the four
normal nucleosides adenosine (A), guanosine (G), cytidine (C) and
uridine (U) are modified [2,3]. The modifications are introduced
post-transcriptionally, and the formation of a modified nucleoside
may require one or several enzymatic steps [2,3]. Of the 50
modified nucleosides so far identified in eukaryotic tRNAs, 25 are
present in cytoplasmic tRNAs from S. cerevisiae [2,4,5]. In the
anticodon region, especially in positions 34 (wobble position) and
37, nucleosides are frequently modified. Modified nucleosides in
these positions are important for reading frame maintenance and
efficient decoding during translation [2,3]. In yeast, there are in
total 42 cytosolic tRNA species, of which 11 have a uridine at
position 34 modified to 5-carbamoylmethyluridine (ncm5U), 5-
carbamoylmethyl-29-O-methyluridine (ncm5Um), 5-methoxycar-
bonylmethyl-uridine (mcm5U) or 5-methoxycarbonylmethyl-2-
thiouridine (mcm5s2U) [6]. The formation of these nucleosides
requires addition of mcm or ncm side chains at the 5-position of
the uracil moity and a subset of these tRNAs also have a thio (s2)
group at the 2-position of U34 or a methylation at the 29 position of
the ribose.
The common step in synthesis of ncm5 and mcm5 side chains
at U34 in tRNAs requires at least 11 gene products (Figure 1).
Deletion strains missing one of ELP1-ELP6, KTI11, KTI12, KTI14
or SIT4 genes, or both SAP185and SAP190 genes completely
lack the mcm5U, mcm5s2U and ncm5U nucleosides, whereas a
kti13 deletion mutant show dramatically reduced levels of these
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nucleosides [7,8]. In strains with these genes mutated, no
intermediates of mcm5U or ncm5U have been detected, whereas
s2U is detected in tRNAs normally containing mcm5s2U [7,8,9,
10,11,12]. Thus, these gene products are required for an early step
in synthesis of mcm5 and ncm5 groups (Figure 1). The earliest
intermediate in the synthesis of mcm5U and ncm5U that has been
detected is cm5U, and there is evidence that it originates from a
metabolite related to acetyl-CoA [13] (Figure 1).
The ELP1-ELP6 gene products form the Elongator complex
that consists of a core complex Elp1-Elp3 and a sub complex
Elp4-Elp6 [14,15,16]. In the C-terminal part of Elp3p there is
a potential acetyl-CoA binding domain [17], and the central
region shares homology to the Radical SAM superfamily [18].
Members of this family contain an iron-sulphur (FeS) cluster
and use S-adenosylmethionine (SAM) to catalyze a variety of
radical reactions. The presence of a FeS cluster and ability
to bind SAM has been verified for the M. jannaschii Elp3p
homologue [18], whereas no binding of SAM to S. cerevisiae
Elongator complex was observed [19]. At least Elp1 and
Elp3 of Elongator core complex are in intimate contact with
tRNA that is modified with a mcm side chain at U34 [7]. The
KTI11-KTI14, SIT4 or SAP185 SAP190 gene products seem to
regulate the activity of Elongator complex [20,21,22,23,24,25,
26,27,28,29,30].
The last step in formation of mcm5 side chain of U34 is a
methyl esterification of cm5 [13], and requires Trm9p/Trm112p
in yeast and ALKBH8/TRM112 in mammalians [31,32,33]. We
confirm that Trm112p is also required for the last step of mcm5
side chain formation at position 34 in a subset of tRNAs. In vivo,
Trm112p is essential for the methyl esterification to mcm5U34,
and in vitro Trm112p improves the methyltransferase activity of
Trm9p. The observation that the major intermediates accumu-
lating in trm9 and trm112 mutants are ncm5U and ncm5s2U and
not the expected cm5U and cm5s2U raises the question; what is
the order of intermediates formed in biosynthesis of the mcm5
side chain of U34?
Materials and Methods
Yeast strains, media and genetic procedures
Strains used in this report, except those from the yeast deletion
collection (Open Biosystems), are listed in Table S1A. Yeast
media, genetic procedures and yeast transformation have been
described previously [34]. To construct mtq2::KanMX6 and
trm112::KanMX6 deletions, oligonucleotides (2104 and 2015,
1391 and 1392) in Table S1B containing 45nt sequence
homology flanking the MTQ2 and TRM112 genes were used to
amplify the KanMX6 cassette [35]. To delete TRM9, TRM11 and
LYS9 in W303 strains, chromosomal DNA from the correspond-
ing null mutants in the yeast deletion collection (Open
Biosystems) were used as templates. The KanMX6 cassette
together with 300–500 base pair flanking sequences to each
gene were amplified with specific primers (1035 and 1036 for
TRM9, 1950 and 1951 for TRM11, and 2059 and 2060 for LYS9)
listed in Table S1B. The PCR products were introduced into
diploid yeast strain UMY3104 and transformants were selected
on YEPD plates containing 200 mg/ml Geneticin (G418).
Transformants were sporulated and tetrad analysis verified a
2:2 segregation of mating type and G418 resistance. Deletions
were confirmed by PCR. The double mutants trm9D trm11D,
trm9D lys9D, trm9D mtq2D, trm11D lys9D, trm11D mtq2D and lys9D
mtq2D were generated by crossing the single mutants. The
quadruple mutant was generated in a cross between trm9D lys9D
and trm11D mtq2D.
Plasmid constructions
To generate the expression vector for the Trm9 protein, TRM9
gene was amplified by PCR using oligos 2015 and 2016 (Table
S1B) and W303-1A genomic DNA as template. The PCR product
was digested with BamH1 and HindIII, and subcloned to the
corresponding sites of the expression vector pRSF-Duet1 (Nova-
gen), generating an in frame fusion with the histidine tag. To
construct the Trm9p-Trm112p co-expression vector, the TRM112
gene was amplified from W303-1A genomic DNA using oligos
2013 and 2014 (Table S1B) and cloned into the pRSF-Duet1-
TRM9 vector using NdeI and XhoI.
Protein purification
The expression vectors were introduced into BL21(DE3)pLysS
competent cells. Overnight cultures of transformed cells were
grown in LB media containing 50 mg/ml Kanamycin at 37uC.
Cultures were diluted to OD600 0.05 and grown to OD600 0.5 at
37uC. Cultures were placed on ice for 10 minutes. IPTG was
added to a final concentration of 120 mg/ml and protein
expression was induced at 15uC overnight. Harvested cell pellets
Figure 1. Model for formation of mcm5 side chain at wobble
uridines. The Elongator complex (Elp1-Elp6) and its potential
regulators are required for the formation of cm5U. A methyl group is
added to cm5U by Trm9p/Trm112p complex in tRNA species that in
their mature form should have a mcm5 side chain. The cm5U in other
tRNA species are converted to ncm5U by an unknown enzyme. For
tRNAs that should contain a s2 group, presence of a mcm5 or ncm5 side
chain is a prerequisite for efficient thiolation.
doi:10.1371/journal.pone.0020783.g001
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were washed once by 0.9% NaCl and resuspended in breaking
buffer (20 mM Tris pH 8.0, 10 mM imidazole, 150 mM NaCl,
0.2% NP-40, 2 mM b-mercaptoethanol) in the presence of
proteinase inhibitor cocktail (Roche). Cells were broken by
sonication and the cell extract was clarified by centrifugation at
16,000 g for 1 hour. The supernatant was mixed with TALON
resin, equilibrated with breaking buffer and incubated at 4uC for
2 hours. The protein bound TALON resin was first washed with
buffer 1 (20 mM Tris pH 8.0, 10 mM imidazole, 150 mM NaCl,
2 mM b-mercaptoethanol) and then with buffer 2 (20 mM Tris
pH 8.0, 10 mM imidazole, 500 mM NaCl, 2 mM b-mercapto-
ethanol). Proteins were eluted with 330 mM imidazole and
dialyzed overnight against storage buffer (25 mM Tris pH 8.0,
150 mM NaCl, 5 mM DTT, 10% glycerol) and kept at 4uC for
future use.
Methyltransferase reaction
In the methyltransferase reaction, 50 ml of 2X reaction buffer
(200 mM Tris 7.5, 0.2 mM EDTA, 20 mM MgCl2, 20 mM
NH4Cl) was mixed with 20 ml [
3H]AdoMet (0.55 mCi/ml, Perkin
Elmer) and 20 mg tRNA, incubated at 37uC for 5 minutes. The
methyltransferase reaction was initiated by adding 10 mg Trm9p
or Trm9p-Trm112p. Aliquots of the reaction was withdrawn at
different time points and mixed with 1 ml of 5% ice cold
trichloroacetic acid (TCA). The tubes were incubated on ice for 10
minutes and samples were vacuum filtered through nitrocellulose
filter (Millipore 0.45 mm). The [3H] incorporation was measured
using a Wallac 1409 scintillation counter. To analyze [3H]
incorporation in total tRNA by HPLC, 200 mg of tRNA was used.
After 30 minutes of methyltransferase reaction, 2.5 volume of 99%
ice cold ethanol was added into the reaction and samples were
Figure 2. trm9 and trm112 mutants are lacking the mcm5 side-chain in tRNAArg
mcm5UCU
at wobble uridines. HPLC analysis of modified tRNA
nucleosides from wild-type (UMY3169, left panels), trm9::KanMX4 (Open Biosystems, middle panels) and trm112::KanMX4 (UMY3330, right panels).
Arrows in red and black indicate expected retention time of mcm5U and cm5U, respectively. Arrow heads in red and black indicate expected retention
time of m2G and ncm5U, respectively. (A), Part of the chromatogram between retention times 34 and 44 min is shown. (B), Part of the chromatogram
between retention times 7 and 17 min is shown. The small peak in wild-type at 14 min represents an unrelated compound with a spectrum different
from ncm5U. The chromatograms were monitored at 254 nm.
doi:10.1371/journal.pone.0020783.g002
Table 1. Relative amounts of various modified nucleosides in tRNAArgUCU and tRNA
Glu
UUC isolated from wild type, trm9D and
trm112D strains.
tRNA
Arg
UCU tRNA
Glu
UUC
cm5U/Y ncm5U/Y mcm5U/Y cm5U/Y ncm5U/Y mcm5U/Y cm5s2U/Y ncm5s2U/Y mcm5s2U/Y
WT 0.016 0.044 0.183 ND ND ND 0.029 ND 0.220
trm9D 0.051 0.199 ND 0.065 0.028 ND 0.013 0.191 ND
trm112D 0.046 0.149 ND 0.044 0.044 ND 0.022 0.161 ND
Pseudouridine (Y) was used as the internal control. The numbers displayed are the ratios (modified nucleoside/Y). ND: not detected. The modified nucleosides cm5U,
ncm5U, mcm5U and Y were monitored at 254 nm, and cm5s2U, ncm5s2U and mcm5s2U were monitored at 314 nm as thiolated nucleosides absorb well at this
wavelength, while nonthiolated nucleosides do not.
doi:10.1371/journal.pone.0020783.t001
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centrifuged for 30 minutes in eppendorf tubes at maximum speed.
The pellet was resuspended in MQ water, digested with nuclease
P1 and analyzed by HPLC [36]. The [3H] incorporation was
monitored by a flow scintillation analyzer (Packard Bioscience).
Single tRNA isolation
Yeast cells were grown in 2L YEPD at 30uC to OD600= 1.5.
Total tRNA was prepared as described [36]. Single tRNA
species were isolated from total tRNA by hybridizing to
biotinylated complementary oligonucleotides [36] and separated
from total tRNA by attachment to streptavidin coated Dyna-
beads M-280 (Invitrogen). The single tRNAs were digested to
nucleosides with nuclease P1 followed by bacterial alkaline
phosphatase (BAP) treatment [0.2 M (NH4)2SO4 pH 8.3], and
analyzed by HPLC [37].
Results and Discussion
Trm112p is required for the methyl esterification of
mcm5U and mcm5s2U
In a global analysis of protein complexes in yeast, Trm112p
was found to interact with three methyltransferases Trm9p,
Trm11p and Mtq2p [38,39,40,41]. In addition, Trm112p
interacts with the saccharopine dehydrogenase Lys9p, the essential
DEAH-box ATP-dependent RNA helicase Ecm16p and an
essential component of the RSC chromatin remodeling complex
Figure 3. Nucleoside ncm5U is not generated by amidation of cm5U during conversion of tRNA into nucleosides. Synthetic cm5U (A
and B) or a mixture of synthetic cm5U and ncm5U (C and D) were treated with nuclease P1 for 16 hours, followed by a 2 hours incubation with either
water (A and C) or bacterial alkaline phosphatase (BAP) (B and D). Parts of the chromatogram of HPLC analysis between 5 and 20 min are shown. The
chromatograms were monitored at 254 nm.
doi:10.1371/journal.pone.0020783.g003
Figure 4. Growth phenotypes. Wild type (UMY2067), trm112D (UMY3679), trm9D (UMY3267), trm11D (UMY3677), lys9D (UMY3650), mtq2D
(UMY3675), trm9D mtq2D (UMY3673) and trm9D trm11D lys9D mtq2D (UMY3680) strains were cultivated in YEPD at 30uC and 37uC.
doi:10.1371/journal.pone.0020783.g004
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Sfh1p [38,39,40,41]. The N2-Monomethylguanosine-10 (m2G10)
methyltransferase Trm11p, as well as the eRF1 methyltranferase
Mtq2p, has to be in complex with Trm112p to be active [42,43].
Trm9p is required for the methyl esterification of modified uridine
nucleosides, resulting in the formation of 5-methylcarbonylmethy-
luridine (mcm5U34) and 5-methylcarbonylmethyl-2-thiouridine
(mcm5s2U34) present in a subset of tRNA species in yeast,
including tRNA
Arg
mcm5UCU
and tRNAGlumcm5s2UUC [31]. In the methyl
esterification reaction of these tRNAs, cm5U34 and cm
5s2U34 were
suggested to be the substrates [13,31,32,].
Both Trm9 and Trm112 are required for methyl esterification to
mcm5U and mcm5s2U [31,32,33]. To analyze the tRNA modifi-
cation status in these two mutants, total tRNA from trm9D, trm112D
and wild type strains were isolated, digested to nucleosides and
analyzed by HPLC. Similar to previous reports [31,32,33], total
tRNA isolated from trm9 and trm112 deletion mutants lacked
mcm5U and mcm5s2U nucleosides (data not shown). In order to
provide a more detailed analysis of all possible nucleoside
intermediates in trm9D and trm112D mutants, single tRNA species,
tRNA
Arg
mcm5UCU
, tRNAGlumcm5s2UUC and tRNA
Pr o
ncm5UGG, were isolat-
ed from wild type, trm9D and trm112D strains and the purified
tRNAs were digested to nucleosides and analyzed by HPLC
(Figure 2, Table 1, data not shown). As expected, the ncm5U
nucleoside was present in tRNAPr oncm5UGG independent if the tRNA
was isolated from trm9D, trm112D or wild type strains (data not
shown). The mcm5U and mcm5s2U nucleosides were present in
tRNA
Arg
mcm5UCU
and tRNAGlumcm5s2UUC isolated from wild type but
not from trm9D and trm112D cells (Figure 2, Table 1). In
tRNA
Arg
mcm5UCU
isolated from trm9D and trm112D strains, we
observed the appearance of ncm5U and cm5U (Figure 2B,
Table 1). Interestingly, the major intermediate of the mcm5U
nucleoside generated in the trm9D and trm112D mutants is ncm5U
(Figure 2, Table 1). The presence of ncm5U and cm5U has also been
observed in tRNA
Arg
mcm5s2UCU
, tRNAGlumcm5s2UUC and tRNA
Sec
isolated from an alkbh82/2 mice [32,44]. In tRNAGlumcm5s2UUC
isolated from the trm9D and trm112D strains, there was a complete
lack of mcm5s2U and a concomitant increase of cm5U, ncm5U and
ncm5s2U (Table 1). The presence of cm5U supports the earlier
observation that formation of a completed mcm5 side chain appears
to be a prerequisite for efficient and complete thiolation of position
2 in mcm5s2U containing tRNAs [10,11,12,32]. An unex-
pected observation was that the major species accumulating in
tRNA
Arg
mcm5s2UCU
and tRNAGlumcm5s2UUC isolated from trm9D and
trm112D strains were ncm5U and ncm5s2U, respectively (Table 1).
We considered the possibility that the ncm5 side chain was
spontaneously generated from cm5 by amidation during the
bacterial alkaline phosphatase (BAP) treatment in the digestion step
of tRNA to nucleosides for HPLC analysis. To test this hypothesis,
synthetic cm5U nucleoside was treated in the same way as in the
digestion step of tRNA and analyzed by HPLC (Figure 3). We did
not detect any conversion of cm5U to ncm5U (Figure 3) indicating
that formation of ncm5U is enzymatically catalyzed and not an
artifact of the sample preparation procedure.
In addition to Trm9p, Trm112p also interacts with Trm11p,
Lys9p andMtq2p encoded by non-essential genes, and Ecm16p and
Sph1p encoded by essential genes [38,39,40,41]. Therefore, we also
analyzed single tRNA species tRNA
Arg
mcm5UCU
, tRNAGlumcm5s2UUC
and tRNAPr oncm5UGG from trm11D, lys9D and mtq2D strains. Trm11p
and Trm112p are essential for formation of the m2G nucleoside
[42]. Consistently, tRNA
Arg
mcm5UCU
isolated from trm11D or trm112D
strains does not have the m2G modified nucleoside, whereas the
same tRNA from wild-type has m2G (Figure 2 and S1). In single
tRNAs from lys9D and mtq2D strains, there was no notable change
in modified nucleosides as assessed by HPLC analysis (Figure S1,
data not shown). A deletion of the TRM112 gene causes a dramatic
reduction in growth and a mtq2D strain also shows a clear reduction
in growth, whereas trm11D, lys9D or trm9D strains show mild growth
defects in YEPD medium at both 30uC and 37uC (Figure 4). We
considered the possibility that strains with multiple null alleles of
genes encoding Trm112p interacting proteins would show additive
growth defects, possibly mimicking a trm112D null allele. Since two
Trm112p associated proteins, Ecm16 and Sfh1, are encoded by
essential genes, we were only able to make strains with combinations
of the trm11D, lys9D, trm9D, and mtq2D alleles. We first made the
double mutants trm11D lys9D, trm11D trm9D, trm11D mtq2D, lys9D
trm9D, lys9D mtq2D and trm9D mtq2D. No additive growth reduction
was observed in any of the constructs at both 30uC and 37uC
(Figure 4, data not shown), in contrast to the previously observed
growth defect of the trm9D mtq2D mutant [33]. Further we made a
trm11D lys9D trm9D, mtq2D quadruple mutant strain that grew like a
mtq2D strain at both 30uC and 37uC (Figure 4). These data show
that the poor growth of trm112D cells is not entirely caused by
defects in tRNA modification, eRF1 methylation and dehydroge-
nase activity in the quadruple mutant. Possibly it is caused by
reduced function of Ecm16p or Sfh1p which might require the
interaction with Trm112p to be fully active.
Trm112p/Trm9p complex efficiently incorporates methyl
groups into trm9 substrate tRNA in vitro
Trm9p has been shown to catalyze the methyl esterification to
mcm5U and mcm5s2U in vitro [31]. We cloned the TRM9 gene into
the expression vector pRSF duet to produce 6xHis-Trm9p
recombinant protein in E. coli. We also made a pRSF duet vector
construct, simultaneously expressing the 6xHis-Trm9p recombi-
nant protein and a non-tagged Trm112p. When Trm9p was
expressed alone, the majority of Trm9p recombinant protein was
insoluble (Figure 5A), and the solubility of Trm9p dramatically
improved when Trm112p was co-expressed with Trm9p.
Purification of Trm9p by virtue of its 6xHis tag resulted in co-
purification of Trm112p (Figure 5A), indicating that Trm9p forms
a stable complex with Trm112p.
Purified Trm9p and Trm9/Trm112p complex was used to
methylate total tRNA isolated from wild type and a trm9 deletion
strains in vitro. Saponification of total tRNA with sodium hydroxide
leads to the production of cm5U and cm5s2U from mcm5U and
mcm5s2U, and this method has previously been used to generate
Figure 5. Trm9p/Trm112p complex efficiently catalyzes the methyl incorporation into trm9 substrate tRNA. (A) SDS-PAGE analysis of
histidine tagged Trm9p expressed alone or co-expressed with Trm112p and purified from E. coli. The gel was stained with Colloidal Blue (Invitrogen). Lane 1:
Molecular weight standard (PageRuler prestained, Fermentas). Lane 2: Soluble fraction of extract from E. coli strains expressing Trm112p and histidine tagged
Trm9p. Lane 3: Soluble fraction of extract from E. coli strains expressing histidine tagged Trm9p. Lane 4: Pellet from crude extract of E. coli strains expressing
Trm112p and histidine tagged Trm9p. Lane 5: Pellet from crude extract of E. coli strains expressing histidine tagged Trm9p. Lane 6: Trm112p co-purified with
histidine tagged Trm9 protein. Lane 7: Purified histidine tagged Trm9 protein. (B) [3H] methyl incorporation into tRNA as a function of time. Substrates were
total tRNA preparations from strain UMY2067 (wild-type) and UMY3267 (trm9D). (&) and (m) are methyl incorporation reactions into wild-type tRNA by using
Trm9p or Trm9p/Trm112p as enzyme. (#) is methyl incorporation reaction into trm9 tRNA by using Trm9p as enzyme. (C). The methyl incorporation into trm9
tRNA using Trm9p/Trm112p as enzyme (e), in addition to the reactions in (B).
doi:10.1371/journal.pone.0020783.g005
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substrates for Trm9p or ALKBH8 [31,32]. However, saponifica-
tion also efficiently degrades tRNA and we found that tRNA
isolated from the trm9 deletion strain was a superior substrate in
the methyl esterification assay (data not shown). To track
methylation of tRNA substrates in vitro, S-adenosylmethionine
containing a tritiated methyl donor group was used together with
tRNA and purified enzyme. When total tRNA from wild type was
used as a substrate, there was a small increase in incorporation of
Figure 6. HPLC analysis of total trm9 tRNA after methyl incorporation by using Trm9p/Trm112p as enzyme. (A–B) Part of the
chromatogram between retention time 10 and 19 min is shown. The arrow in B indicates the expected retention time of cm5U. (C–D). Part of the
chromatogram between retention time 34 and 45 min is shown. The arrow in C indicates the expected retention time of mcm5U. (E–F). Part of the
chromatogram between retention time 47 and 52 min is shown. The arrow in E indicates the expected retention time of mcm5s2U. (G–H). Part of the
chromatogram between retention time 26 and 52 min is shown. Open and closed arrowheads in G and H indicate the expected retention time of
mcm5s2U and cm5U, respectively. Chromatograms in A–F were monitored at 254 nm and at 314 nm in G–H. The dashed line in D, F and H indicates
the migration of isotope labeled nucleoside which overlaps with mcm5U and mcm5s2U, respectively. The Y axis to the left corresponds to absorbance
units and the Y axis to the right shows the [3H] incorporation in cpm.
doi:10.1371/journal.pone.0020783.g006
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radioactive methyl groups with time using either Trm9p or the
Trm9p/Trm112p complex (Figure 5B). In contrast, use of total
tRNA from the trm9D strain and Trm9p leads to a clear but
modest increase in the incorporation of radioactive methyl groups
(Figure 5B). Moreover, the incorporation of radioactive methyl
groups was 20-fold more efficient using Trm9p/Trm112p over
Trm9p alone (Figure 5C). Thus, Trm112p is required for Trm9p
to methylate its substrate tRNA more efficiently in vitro and is a
prerequisite in vivo as no mcm5 nucleosides are formed in a
trm112D mutant (Figure 2, Table 1). In the reaction using tRNA
from the trm9D strain and Trm9p/Trm112p, there was a rapid
incorporation of [3H] methyl groups in the first 5 minutes that
entered to a plateau after 30 minutes (Figure 5C). The reduced
incorporation was not due to enzyme inactivation with time as
adding more enzyme at 30 minutes did not improve incorporation
of radioactivity (data not shown).
Based on HPLC analysis, there is an accumulation of cm5U,
ncm5U, and ncm5s2U in total tRNA from a trm9D strain compared
with a wild-type strain [33] (data not shown). When tRNA isolated
from a trm9D strain was used as substrate in vitro, we observed a
reduction of the cm5U nucleoside and appearance of mcm5U
(Figure 6A-D, Table 2) consistent with cm5U being the substrate of
Trm9 [31,32,33]. Furthermore, the relative amounts of ncm5U
and ncm5s2U did not change after the methylation reaction,
showing that these two nucleosides are not substrates of Trm9p/
Trm112p under these conditions (Table 2) [33]. By using
saponified tRNA, cm5s2U was suggested to be a substrate for
Trm9p or ALKBH8/Trm112 [31,32]. However, cm5s2U was not
detected in total tRNA isolated from trm9 or trm112 mutants [33].
In our analysis of trm9 total tRNA, we observed a very small peak
migrating in the position of cm5s2U, which was absent after the
methylation reaction (Figure 6G-H, Table 2). When [3H]-CH3
was monitored by flow scintillation analyzer coupled to the HPLC,
we found that the incorporated radioactivity migrated with
retention times identical to those known for mcm5U and mcm5s2U
nucleosides (Figure 6D, F and H). As the signal for the tentative
cm5s2U is very weak, we cannot exclude the possibility that
mcm5s2U originated from another species. These observations are
consistent with those shown by Kalhor and Clarke [31,32] and
fully support the assertion that Trm9p is the methyltransferase
catalyzing the formation of mcm5U from cm5U. Why and how
ncm5U and ncm5s2U accumulates in tRNAs from strains lacking
Trm9p or Trm112p, remains to be elucidated.
Alternative mechanisms in formation of the mcm5 side
chain at wobble position
In trm9D or trm112D strains, the major species generated are
ncm5U and ncm5s2U instead of the expected cm5U or cm5s2U.
According to the model proposed in Figure 1, Elongator complex
is required for and might directly catalyze the formation of cm5U.
In the presence of Trm9 and Trm112p, cm5U is rapidly converted
to mcm5U in tRNAs destined to contain a mcm5U nucleoside.
Those tRNAs destined to contain ncm5U are not recognized by
Trm9p/Trm112p and ncm5U is formed by an uncharacterized
enzyme. In order to account for the presence of ncm5U and
Table 2. Relative amounts of various modified nucleosides of total tRNA isolated from the trm9D strain before and after
methylation reaction.
cm5U/Y ncm5U/Y mcm5U/Y cm5s2U/Y ncm5s2U/Y mcm5s2U/Y
Before reaction 0.01752 0.04634 ND 0.00081 0.00571 ND
After reaction 0.00227 0.04707 0.01720 ND 0.00521 0.00132
Pseudouridine (Y) was used as the internal control. The numbers displayed are the ratios (modified nucleoside/Y). ND: not detected. The modified nucleosides cm5U,
ncm5U, mcm5U and Y were monitored at 254 nm, and cm5s2U, ncm5s2U and mcm5s2U were monitored at 314 nm as thiolated nucleosides absorb well at this
wavelength, while nonthiolated nucleosides do not.
doi:10.1371/journal.pone.0020783.t002
Figure 7. An alternative model for formation of mcm5 side
chain at wobble uridines. Elongator complex (Elp1-Elp6) and its
potential regulators catalyzes the formation of ncm5U. The ncm5U is
converted to cm5U by an unknown mechanism in tRNA species that in
their mature form should have a mcm5 side chain. This unknown
mechanism requires Trm9p/Trm112p. In the last step, a methyl group is
added to cm5U by Trm9p/Trm112p complex in these tRNA species. For
tRNAs that should contain a s2 group, presence of a mcm5 or ncm5 side
chain is a prerequisite for efficient thiolation.
doi:10.1371/journal.pone.0020783.g007
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ncm5s2U in tRNAs that normally should contain mcm5U and
mcm5s2U, one has to postulate that in the absence of Trm9p/
Trm112p the uncharacterized enzyme responsible for amidation
also recognizes these tRNA substrates (Figure 2). For tRNAs that
should contain a s2 group, the presence of a mcm5 side chain has
been suggested to be a prerequisite for efficient thiolation [10,12].
We suggest that the presence of ncm5U, but not cm5U, in these
tRNAs also promotes efficient thiolation, resulting in accumulation
of ncm5s2U (Table 1).
The observation that the major U34 intermediates in
tRNA
Arg
mcm5UCU
and tRNAGlumcm5s2UUC are ncm
5U and ncm5s2U
in trm9 and trm112 mutants also supports an alternative model, i. e.
ncm5U is generated before cm5U (Figure 7). Such a model would
require a conversion of ncm5U to cm5U before the Trm9p/
Trm112p complex finally can form mcm5U. A similar mechanism
has been described in Eubacteria that have mnm5 instead of mcm5
side chains and the first intermediate in its synthesis is cmnm5U
[45]. The bi-functional MnmC demodifies cmnm5U to nm5U and
thereafter methylates nm5U to form mnm5U [45,46,47]. By
analogy, the Trm9p/Trm112p complex may be involved in two
reactions; deamination of ncm5U to cm5U, and then catalyzing
formation of mcm5U. The deaminase activity is not necessarily
part of Trm9p or Trm112p. In the absence of Trm9p or
Trm112p, ncm5U accumulates in tRNAs destined to contain
mcm5s2U, liketRNAGluUUC. As postulated in model 1, the presence
of an ncm5 side chain in these tRNAs promotes thiolation,
generating ncm5s2U. MnmC requires flavin adenine dinucleotide
(FAD) as co-factor in the de-modification reaction and SAM in the
methylation reaction. We performed an in vitro reaction with
[3H]AdoMet in the presence or absence of FAD. We assumed if
ncm5U is converted to cm5U in the presence of FAD, more [3H]-
methyl groups would be incorporated into total tRNA isolated
from trm9 deletion strain when FAD is included in the reaction.
Reactions conducted in the presence of FAD did not increase the
incorporation of [3H]-methyl into trm9 deletion tRNA, nor did it
decrease the overall amount of ncm5U as analyzed by HPLC (data
not shown). We also investigated the potential use of other
cofactors in the conversion of ncm5U to cm5U such as NAD+ and
NADP+ without success (data not shown). It remains to be
elucidated which of these two alternative pathways for formation
of mcm5 side chains is used.
Supporting Information
Figure S1 HPLC analysis of modified nucleosides in
tRNA
Arg
mcm5UCU
isolated from wild-type, trm11D, lys9D and
mtq2D strains. Arrows in red and black indicate expected
retention time of mcm5U and cm5U, respectively. Arrow heads in
red and black indicate expected retention time of m2G and
ncm5U, respectively. (A–D), Part of the chromatogram between
retention times 34 and 44 min is shown. (B), Part of the
chromatogram between retention times 7 and 17 min is shown.
The small peak in wild-type at 14 min represents an unrelated
compound with a spectrum different from ncm5U. Absorbance at
254 nm (AU) was used to create the chromatograms.
(EPS)
Table S1 Strains and primers used in this study (see also [48]
and [49]).
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